新云社 update: Chen Yuqing, chairman of Fosun Pharma, proposed a buyback of the company’s A-shares via centralized bidding, with total funding of no less than RMB 250 million and no more than RMB 500 million. The buyback price will not exceed 150% of the average price over the 30 trading days before the board approves the plan, and the program will run for up to 12 months. Repurchased shares will be used for convertible bond conversion, equity incentives and/or employee stock ownership plans.
Fosun Pharma Chair Proposes A-Share Buyback of Up to RMB 500 Million
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
37m ago
Nvidia market cap falls $2.7T in six weeks as tech selloff deepens
1h ago
Bitcoin falls to two-year low as risk-asset selloff deepens
1h ago
Bitcoin falls to $55K as $1.89B in longs liquidated; $60K turns resistance
1h ago
Bitcoin Drops 8% as Crypto Liquidations Hit $2.38 Billion
2h ago
Bitcoin Falls Below $56K to $55,555, Down 53.8% From Record High
2h ago
Crypto market cap falls nearly $800B in a month, down about 27%




